Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 1.00 |
| ▸ | MAPT | P10636 | 5/20 | 1.00 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 1.00 |
| ▸ | HPGD | P15428 | 3/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 3/20 | 1.00 |
| ▸ | NPC1 | O15118 | 2/20 | 1.00 |
| ▸ | NFKB1 | P19838 | 2/20 | 1.00 |
| ▸ | RAB9A | P51151 | 2/20 | 1.00 |
| ▸ | MEN1 | O00255 | 2/20 | 1.00 |
| ▸ | TP53 | P04637 | 2/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 2/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 2/20 | 1.00 |
| ▸ | CYP2D6 | P10635 | 2/20 | 1.00 |
| ▸ | CYP2C9 | P11712 | 2/20 | 1.00 |
| ▸ | MAPK1 | P28482 | 2/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 2/20 | 1.00 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 1.00 |
| ▸ | S100A4 | P26447 | 1/20 | 1.00 |
| ▸ | MTOR | P42345 | 1/20 | 1.00 |
| ▸ | NFKB2 | Q00653 | 1/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20774334 | 1.00 | ALDH1A1 (1.00) | ALDH1A1MAPTTDP1HPGDKMT2A | |
| SCHEMBL161627 | 1.00 | ALDH1A1 (1.00) | ALDH1A1MAPTTDP1HPGDKMT2A | |
| SCHEMBL11837169 | 0.86 | MAPT (0.74) | ALDH1A1MAPTTDP1HPGDKMT2A | |
| SCHEMBL11837176 | 0.86 | MAPT (0.74) | ALDH1A1MAPTTDP1HPGDKMT2A | |
| SCHEMBL11841569 | 0.82 | ALDH1A1 (0.67) | ALDH1A1MAPTTDP1HPGDKMT2A | |
| SCHEMBL2578234 | 0.81 | TLR9 (1.00) | ALDH1A1MAPTTDP1HPGDKMT2A | |
| SCHEMBL2578236 | 0.81 | TLR9 (1.00) | ALDH1A1MAPTTDP1HPGDKMT2A | |
| SCHEMBL14141134 | 0.81 | ALDH1A1 (0.68) | ALDH1A1MAPTTDP1HPGDKMT2A | |
| SCHEMBL20774379 | 0.81 | ALDH1A1 (0.68) | ALDH1A1MAPTTDP1HPGDKMT2A | |
| SCHEMBL20774381 | 0.81 | ALDH1A1 (0.68) | ALDH1A1MAPTTDP1HPGDKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 587 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260035753-A1 | METHODS OF DETERMINING BACTERIA AND MANUFACTURING A FIBROUS WEB AND TOOLS AND USES RELATED THERETO | KEMIRA OYJ (FI) | 2026-02-05 | — | — | US | claimed |
| EP-4662200-A1 | METHOD FOR PREPARING ARYLVINYLSULPHONES | Kemira OYJ (FI) | 2025-12-17 | — | — | EP | claimed |
| EP-3528776-B1 | REDUCED-ETHANOL MOUTH RINSE FORMULATIONS | KENVUE BRANDS LLC (US) | 2025-11-26 | — | — | EP | claimed |
| US-20250059074-A1 | ANTIMICROBIAL SYSTEM AND METHOD | KEMIRA OYJ (FI) | 2025-02-20 | — | — | US | claimed |
| EP-4214190-B1 | METHOD FOR PREPARING ARYLVINYLSULPHONES | KEMIRA OYJ (FI) | 2025-02-19 | — | — | EP | claimed |
| US-20240383784-A1 | ANTIMICROBIAL SYSTEM AND METHOD | KEMIRA OYJ (FI) | 2024-11-21 | — | — | US | claimed |
| EP-4447685-A1 | ANTIMICROBIAL SYSTEM AND METHOD | Kemira OYJ (FI) | 2024-10-23 | — | — | EP | claimed |
| EP-4447666-A1 | ANTIMICROBIAL SYSTEM AND METHOD | Kemira OYJ (FI) | 2024-10-23 | — | — | EP | claimed |
| US-12114659-B2 | Method for controlling growth of microorganisms and/or biofilms in an industrial process | KEMIRA OYJ (FI) | 2024-10-15 | — | — | US | claimed |
| WO-2024199939-A1 | METHOD FOR PREPARING ARYLVINYLSULPHONES | KEMIRA OYJ (FI) | 2024-10-03 | — | — | WO | claimed |
| WO-2006081327-A2 | SMALL MOLECULES THAT REDUCE FUNGAL GROWTH | UNIVERSITY OF VERMONT AND STATE AGRICULTURAL COLLEGE (US) | 2006-08-03 | — | — | WO | claimed |
| US-20040241166-A1 | Screening by contacting inhibitor (sulindac) with endothelial cells activated by blood platelets, and determining secretion of MCP-1 (Monocyte chemoattractant protein-1); for treatment and prevention of atherosclerosis | PROCORDE GMBH (DE) | 2004-12-02 | — | — | US | claimed |
| EP-1372689-B1 | USE OF IKK-BETA INHIBITORS AND METHOD FOR DISCOVERY OF SAID INHIBITORS | PROCORDE GMBH (DE) | 2004-07-14 | — | — | EP | claimed |
| WO-1997007683-A1 | LOW-NITRITE COMPOSITION FOR CURING MEAT AND PROCESS FOR PREPARING LOW-NITRITE CURED MEAT PRODUCTS | FOOD BIOTEK CORPORATION (CA) | 1997-03-06 | — | — | WO | claimed |
| EP-0122062-B1 | METHOD FOR PRESERVATION OF MEAT PRODUCTS | STAUFFER CHEMICAL COMPANY (US) | 1988-05-18 | — | — | EP | claimed |
| EP-0093792-B1 | METHOD FOR CONTROLLING ALGAE | STAUFFER CHEMICAL COMPANY (US) | 1986-09-10 | — | — | EP | claimed |
| EP-0122062-A2 | Method for preservation of meat products | STAUFFER CHEMICAL COMPANY (US) | 1984-10-17 | — | — | EP | claimed |
| US-4443484-A | INHIBITING GROWTH OF CLOSTRIDIUM, 3-(4-TOLYLSULFONYL)ACRYLONITRILE, ALKALI NITRITE | STAUFFER CHEMICAL COMPANY (US) | 1984-04-17 | — | — | US | claimed |
| EP-0093792-A1 | Method for controlling algae | STAUFFER CHEMICAL COMPANY (US) | 1983-11-16 | — | — | EP | claimed |
| US-4331681-A | Method for controlling algae | STAUFFER CHEMICAL COMPANY (US) | 1982-05-25 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260035753-A1 | METHODS OF DETERMINING BACTERIA AND MANUFACTURING A FIBROUS WEB AND TOOLS AND USES RELATED THERETO | POLL, UROD, RNGTT | ALDH1A1 2058/4885MAPT 228/4885TDP1 162/4885 |
| US-20250059074-A1 | ANTIMICROBIAL SYSTEM AND METHOD | HAO2, APEH, CHCHD6 | ALDH1A1 577/4885MAPT 4815/4885TDP1 4387/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.